The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Ipamorelin Peptide Growth Hormone Research Compound An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica Peptide Research Overview Mechanisms, Applications & Insights